1. Case Report: Therapeutic and immunomodulatory effects of plasmapheresis in long-haul COVID.
- Author
-
Kiprov DD, Herskowitz A, Kim D, Lieb M, Liu C, Watanabe E, Hoffman JC, Rohe R, Conboy MJ, and Conboy IM
- Subjects
- Aged, Humans, Leukocytes, Mononuclear, Male, Plasma Exchange, Plasmapheresis, Post-Acute COVID-19 Syndrome, COVID-19 complications, COVID-19 therapy
- Abstract
Many patients with COVID-19 experience a range of debilitating symptoms months after being infected, a syndrome termed long-haul COVID. A 68-year-old male presented with lung opacity, fatigue, physical and cognitive weaknesses, loss of smell and lymphocytopenia. After rounds of therapeutic plasma exchange (TPE), the patient returned to normal activities and work. Mechanistically in the patient's peripheral blood mononuclear cells (PBMCs), markers of inflammatory macrophages diminished and markers of lymphocytes, including natural killer (NK) cells and cytotoxic CD8 T-cells, increased. Circulating inflammatory proteins diminished, while positive regulators of tissue repair increased. This case study suggests that TPE has the capacity to treat long-haul COVID., Competing Interests: Competing interests: Dobri Kiprov and Regina Rohe are owners of Global Apheresis, which performs the procedure used in this case study. 655 Redwood Highway, Suite 370, Mill Valley, CA 94941, (Copyright: © 2022 Kiprov DD et al.)
- Published
- 2021
- Full Text
- View/download PDF